✦ LIBER ✦

Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: Rationale and design of the HEBE trial—A prospective, multicenter, randomized trial

✍ Scribed by Alexander Hirsch; Robin Nijveldt; Pieter A. van der Vleuten; Bart J. Biemond; Pieter A. Doevendans; Albert C. van Rossum; Jan G. Tijssen; Felix Zijlstra; Jan J. Piek

Book ID: 116190511
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 248 KB
Volume: 152
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2006.02.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intracoronary infusion of autologous mon

Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial

✍ Alexander Hirsch; Robin Nijveldt; Pieter A. van der Vleuten; René A. Tio; Willem 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

Design and rationale for the Myocardial

Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: A multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction

✍ Noémi Nyolczas; Mariann Gyöngyösi; Gilbert Beran; Markus Dettke; Senta Graf; Hei 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 244 KB